InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,564.41
(
1.08%
)
US TECH 100
19,292.80
(
1.49%
)
Dow Jones
40,421.36
(
0.33%
)
Brent Oil
81.55
(
-0.89%
)
Bitcoin
67,746.31
(
-0.60%
)

Replies to post #213 on ObsEva SA (OBSV)

Replies to #213 on ObsEva SA (OBSV)
icon url

Frankestin

03/10/22 4:15 AM

#214 RE: Frankestin #213

Additional data from the 6-month analysis are expected in 1Q:22.
It’s NOW
Additional data from the post-treatment follow-up of the Phase 3 EDELWEISS 3 trial are expected in 2Q:22 and from the post-treatment follow-up of the extension study in 4Q:22.